104 related articles for article (PubMed ID: 29665914)
21. Bone marrow involvement by non-Hodgkin's lymphoma: the clinical significance of morphologic discordance between the lymph node and bone marrow. Nebraska Lymphoma Study Group.
Conlan MG; Bast M; Armitage JO; Weisenburger DD
J Clin Oncol; 1990 Jul; 8(7):1163-72. PubMed ID: 1694234
[TBL] [Abstract][Full Text] [Related]
22. Bone marrow involvement in non-Hodgkin's lymphoma in Zimbabwe.
Adewuyi B; Coutts A; Levy L; Klein S; Muronda C
East Afr Med J; 1994 Dec; 71(12):773-5. PubMed ID: 7705245
[TBL] [Abstract][Full Text] [Related]
23. Inflammatory malignant fibrous histiocytoma: distinction from Hodgkin's disease and non-Hodgkin's lymphoma by a panel of leukocyte markers.
Khalidi HS; Singleton TP; Weiss SW
Mod Pathol; 1997 May; 10(5):438-42. PubMed ID: 9160307
[TBL] [Abstract][Full Text] [Related]
24. FDG-PET in the detection of bone marrow disease in Hodgkin's disease and aggressive non-Hodgkin's lymphoma and its impact on clinical management.
Pelosi E; Penna D; Deandreis D; Chiappella A; Skanjeti A; Vitolo U; Bisi G
Q J Nucl Med Mol Imaging; 2008 Mar; 52(1):9-16. PubMed ID: 18235420
[TBL] [Abstract][Full Text] [Related]
25. [Diagnosis and Prognosis Value of Bone Marrow Aspirate Detection for the Bone Marrow Involvement in Non-Hodgkin's Lymphoma Patients].
Gao F; Ke XY; Wang J; Zhu MX; Hu K
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Apr; 28(2):488-494. PubMed ID: 32319384
[TBL] [Abstract][Full Text] [Related]
26. [Lymphoid depletion type 4 Hodgkin disease. Anatomoclinical review of 35 cases].
Eghbali H; Pétorin C; de Mascarel I; Trojani M; Hoerni-Simon G; Soubeyran P; Hoerni B
Bull Cancer; 1994 Oct; 81(10):866-70. PubMed ID: 7734769
[TBL] [Abstract][Full Text] [Related]
27. Prolonged disease-free survival after autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma with a poor prognosis.
Takvorian T; Canellos GP; Ritz J; Freedman AS; Anderson KC; Mauch P; Tarbell N; Coral F; Daley H; Yeap B
N Engl J Med; 1987 Jun; 316(24):1499-505. PubMed ID: 3295542
[TBL] [Abstract][Full Text] [Related]
28. Utilization of 18F-FDG PET/CT as a staging tool in patients with newly diagnosed lymphoma.
Cho SF; Chang CC; Liu YC; Chang CS; Hsiao HH; Liu TC; Huang CT; Lin SF
Kaohsiung J Med Sci; 2015 Mar; 31(3):130-7. PubMed ID: 25744235
[TBL] [Abstract][Full Text] [Related]
29. Detection of bone marrow minimal disease in non-Hodgkin's lymphoma patients by gene rearrangement analysis.
Bregni M; Borrello MG; Siena S; Orazi A; Biassoni D; Bonadonna G; Gianni AM
Haematologica; 1989; 74(4):397-400. PubMed ID: 2507414
[TBL] [Abstract][Full Text] [Related]
30. Hodgkin's lymphoma is a rare form of clonal haematological non-mast cell disease in systemic mastocytosis.
Gasljevic G; Grcar-Kuzmanov B; Grosel A; Sever M; Gazic B; Kloboves-Prevodnik V
Diagn Pathol; 2015 Mar; 10():5. PubMed ID: 25881198
[TBL] [Abstract][Full Text] [Related]
31. Bone marrow flow cytometry in staging of patients with B-cell non-Hodgkin lymphoma.
Kim B; Lee ST; Kim HJ; Kim SH
Ann Lab Med; 2015 Mar; 35(2):187-93. PubMed ID: 25729719
[TBL] [Abstract][Full Text] [Related]
32. Bone marrow in pediatric patients with Hodgkin's disease.
Khan FS; Hasan RF
J Ayub Med Coll Abbottabad; 2012; 24(2):54-7. PubMed ID: 24397053
[TBL] [Abstract][Full Text] [Related]
33. Bone morphology after bone marrow transplantation for Hodgkin's and non-Hodgkin's lymphoma.
Michelson JD; Gornet M; Codd T; Torres J; Lanighan K; Jones R
Exp Hematol; 1993 Mar; 21(3):475-82. PubMed ID: 8440346
[TBL] [Abstract][Full Text] [Related]
34. Lack of utility of CD20 immunohistochemistry in staging bone marrow biopsies for diffuse large B-cell lymphoma.
Baiyee D; Warnke R; Natkunam Y
Appl Immunohistochem Mol Morphol; 2009 Mar; 17(2):93-5. PubMed ID: 19521275
[TBL] [Abstract][Full Text] [Related]
35. [Detection of bone marrow involvement by lymphoma cells in patients with B-NHL by using flow cytometry analysis].
Wang W; Gao L; Wang LL; Li MY; Li YY; Zhao W; Xu YY; Ding Y; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Oct; 18(5):1204-7. PubMed ID: 21129261
[TBL] [Abstract][Full Text] [Related]
36. Bone marrow involvement in systemic ALK+ anaplastic large cell lymphoma: morphological resemblance with Hodgkin's lymphoma.
Naeem S; Bukhari MH; Khurshid I; Hameed A
J Coll Physicians Surg Pak; 2006 Feb; 16(2):148-9. PubMed ID: 16499814
[TBL] [Abstract][Full Text] [Related]
37. [The value of combined use of bone marrow smear and section in lymphoma for diagnosis and staging].
Cui P; Lou F; Fu Y
Zhonghua Nei Ke Za Zhi; 1999 Jul; 38(7):473-5. PubMed ID: 11798685
[TBL] [Abstract][Full Text] [Related]
38. Role of immunohistochemistry in staging diffuse large B-cell lymphoma (DLBCL).
Talaulikar D; Dahlstrom JE; Shadbolt B; Broomfield A; McDonald A
J Histochem Cytochem; 2008 Oct; 56(10):893-900. PubMed ID: 18574254
[TBL] [Abstract][Full Text] [Related]
39. Bone marrow diagnosis in lymphoproliferative disorders: comparison of results obtained from conventional histomorphology and immunohistology.
Thaler J; Dietze O; Denz H; Demuth R; Nachbaur D; Stauder R; Huber H
Histopathology; 1991 Jun; 18(6):495-504. PubMed ID: 1879809
[TBL] [Abstract][Full Text] [Related]
40. Histiocyte-rich B-cell lymphoma. A distinct clinicopathologic entity possibly related to lymphocyte predominant Hodgkin's disease, paragranuloma subtype.
Delabie J; Vandenberghe E; Kennes C; Verhoef G; Foschini MP; Stul M; Cassiman JJ; De Wolf-Peeters C
Am J Surg Pathol; 1992 Jan; 16(1):37-48. PubMed ID: 1728195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
